Millennium Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.07M | Buy |
609,292
+175,914
| +41% | +$887K | ﹤0.01% | 2396 |
|
2025
Q1 | $2.81M | Sell |
433,378
-1,281,705
| -75% | -$8.31M | ﹤0.01% | 2370 |
|
2024
Q4 | $12.6M | Buy |
1,715,083
+610,367
| +55% | +$4.48M | 0.01% | 1412 |
|
2024
Q3 | $8.27M | Sell |
1,104,716
-143,415
| -11% | -$1.07M | ﹤0.01% | 1658 |
|
2024
Q2 | $11.1M | Buy |
1,248,131
+606,804
| +95% | +$5.4M | 0.01% | 1408 |
|
2024
Q1 | $6.5M | Buy |
641,327
+231,270
| +56% | +$2.34M | ﹤0.01% | 1795 |
|
2023
Q4 | $4.13M | Sell |
410,057
-221,712
| -35% | -$2.23M | ﹤0.01% | 2019 |
|
2023
Q3 | $5.92M | Buy |
+631,769
| New | +$5.92M | ﹤0.01% | 1770 |
|
2023
Q2 | – | Sell |
-57,451
| Closed | -$1.34M | – | 4795 |
|
2023
Q1 | $1.34M | Buy |
57,451
+11,760
| +26% | +$274K | ﹤0.01% | 2826 |
|
2022
Q4 | $1.16M | Sell |
45,691
-243,479
| -84% | -$6.16M | ﹤0.01% | 3058 |
|
2022
Q3 | $5.58M | Sell |
289,170
-398,029
| -58% | -$7.67M | ﹤0.01% | 2113 |
|
2022
Q2 | $17.5M | Sell |
687,199
-4,060,995
| -86% | -$103M | 0.01% | 1014 |
|
2022
Q1 | $122M | Buy |
4,748,194
+3,780,369
| +391% | +$97.2M | 0.06% | 125 |
|
2021
Q4 | $40.5M | Buy |
967,825
+802,652
| +486% | +$33.6M | 0.02% | 544 |
|
2021
Q3 | $7.19M | Sell |
165,173
-151,977
| -48% | -$6.61M | ﹤0.01% | 1828 |
|
2021
Q2 | $15M | Buy |
317,150
+276,771
| +685% | +$13.1M | 0.01% | 1050 |
|
2021
Q1 | $2.07M | Sell |
40,379
-65,300
| -62% | -$3.35M | ﹤0.01% | 2787 |
|
2020
Q4 | $2.83M | Buy |
+105,679
| New | +$2.83M | ﹤0.01% | 2280 |
|
2020
Q3 | – | Sell |
-11,222
| Closed | -$460K | – | 3917 |
|
2020
Q2 | $460K | Buy |
+11,222
| New | +$460K | ﹤0.01% | 2778 |
|